Arjo ABFRA:A39 +1.10%73 Median PS Value is €0.00 as of Jun. 28, 2026. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.27 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 70 Medical Distribution companies, Arjo AB ranks worse than 1428570% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Arjo AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €3.645. Arjo AB's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is €0.00.
As of today (2026-06-28), Arjo AB's share price is €2.212. Arjo AB's Median PS Value is €0.00. Therefore, Arjo AB's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Arjo AB's Median PS Value or its related term are showing as below:
FRA:A39's Price-to-Median-PS-Value is not ranked *
in the Medical Distribution industry.
Industry Median: 0.795 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Arjo AB (FRA:A39) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Arjo AB's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.212
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB Median PS Value Related Terms
Arjo AB Median PS Value Historical Data
* Premium members only.
The historical data trend for Arjo AB's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:A39 vs MCK, COR, CAH: Median PS Value Comparison
For the Medical Distribution subindustry, Arjo AB's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB Price-to-Median-PS-Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Arjo AB's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Arjo AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.645.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB (FRA:A39) has a Median PS Value of €0.00 as of Jun. 28, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Arjo AB and its competitors. According to the industry distribution chart, Arjo AB ranks #999999 out of 70 companies in the Medical Distribution industry.
Is Arjo AB's Median PS Value too high?
Arjo AB's current Median PS Value is €0.00. Based on the distribution chart, Arjo AB ranks #999999 out of 70 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's Median PS Value compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #999999 out of 70 companies for Median PS Value. This places Arjo AB in the lower half of its industry. The industry median Median PS Value is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Distribution company?
The median Median PS Value among Medical Distribution companies is 0.80, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Arjo AB and its competitors. For the Medical Distribution industry, the median Median PS Value is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current Median PS Value is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.27, compared to a current price of €2.21 — trading 32.4% below its estimated fair value. The current Median PS Value is €0.00. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current Median PS Value is €0.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (FRA:A39) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of €2.21 is trading 32.4% below its estimated GF Value™ of €3.27.
GuruFocus considers Arjo AB to be Significantly Undervalued.
Key valuation signals for FRA:A39:
Median PS Value: €0.00
GF Value™: €3.27 vs. price of €2.21 (32.4% below fair value)
No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score
Get the complete analysis for FRA:A39
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A39 has been successfully added to your 
